Home/SyntheX/Mike Johnson, PhD
MJ

Mike Johnson, PhD

VP of Drug Discovery

SyntheX

Therapeutic Areas

SyntheX Pipeline

DrugIndicationPhase
Internal Oncology PipelineOncology (specifics not disclosed)Pre-clinical